Circulating IL-8 levels correlate with poor prognosis in multiple solid tumors, including melanoma, renal cell carcinoma, non-small cell lung cancer (NSCLC), and pancreatic, breast, and ovarian cancer [33]. This evidence concerns the gene CXCL8 and ovarian cancer.